Table 3 Mixed-effects logistic regression of AL use by malaria status in quarter 4 compared to baseline. Comparison of AL treatment in intervention and control arm for all patients and by sub-group (transmission zone, age group)

Malaria-negative patients receiving AL

  All ages

8

0.16

0.11

9

0.22

0.07

0.34

0.36

0.140

(0.24–0.53)

(0.24–0.57)

(0.073–0.252)

  Aged 1–5 years

8

0.20

0.12

9

0.27

0.10

0.43

0.48

0.135

(0.24–0.79)

(0.25–0.86)

(0.063–0.262)

  Aged 6 years and over

8

0.14

0.10

9

0.19

0.05

0.28

0.27

0.159

(0.15–0.52)

(0.15–0.52)

(0.081–0.288)

  High transmission

4

0.32

0.18

5

0.36

0.12

0.41

0.45

0.109

(0.25–0.67)

(0.28–0.74)

(0.045–0.241)

  Low transmission

4

0.06

0.02

4

0.11

0.01

0.16

0.16

0.112

(0.05–0.52)

(0.05–0.56)

(0.039–0.281)

  All ages

8

0.71

0.78

9

0.71

0.80

0.88

0.91

0.019

(0.46–1.69)

(0.47–1.77)

(0.007–0.054)

  Aged 1–5 years

8

0.76

0.77

9

0.77

0.82

0.93

0.98

0.029

(0.35–2.49)

(0.37–2.62)

(0.008–0.101)

  Aged 6 years and over

8

0.66

0.79

9

0.64

0.77

0.89

0.87

0.005

(0.36–2.18)

(0.35–2.15)

(0.0003–0.070)

  High transmission

4

0.72

0.85

5

0.79

0.82

0.54

0.54

0.004

(0.23–1.27)

(0.23–1.28)

(0.0002–0.075)

  Low transmission

4

0.71

0.62

4

0.59

0.54

1.10

1.16

0.028

(0.34–3.54)

(0.36–3.78)

(0.006–0.120)